In vitro inhibition of human CYP1A2, CYP2D6, and CYP3A4 by six herbs commonly used in pregnancy

Phytotherapy Research

Volumn 28, Issue 4, 2014, Pages 603-610

  Langhammer, Astrid Jordet ^a   Nilsen, Odd Georg ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

CYP inhibition; cytochrome P450; herb drug interactions; herbal product; in vitro; pregnancy

Indexed keywords

ALCOHOL; CRANBERRY EXTRACT; CYTOCHROME P450 1A2; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; EQUISETUM EXTRACT; FOENICULUM VULGARE EXTRACT; GINGER EXTRACT; PLANT EXTRACT; RASPBERRY EXTRACT; SAMBUCUS NIGRA EXTRACT; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INHIBITION; EQUISETUM; IC 50; IN VITRO STUDY; PLANT LEAF; RASPBERRY;

EQUISETALES; FOENICULUM VULGARE; RUBUS GLAUCUS; SAMBUCUS RACEMOSA; VACCINIUM MACROCARPON; ZINGIBER OFFICINALE;

CYP INHIBITION; CYTOCHROME P450; HERB-DRUG INTERACTIONS; HERBAL PRODUCT; IN VITRO; PREGNANCY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 CYP2D6; CYTOCHROME P-450 CYP3A; EQUISETUM; FEMALE; FOENICULUM; GINGER; HERB-DRUG INTERACTIONS; HUMANS; INHIBITORY CONCENTRATION 50; PLANT EXTRACTS; PREGNANCY; ROSACEAE; SAMBUCUS; TANDEM MASS SPECTROMETRY; VACCINIUM;

EID: 84897969999     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5037     Document Type: Article

References (46)

1. Busby WF, Jr., Ackermann JM, Crespi CL. 1999. Effect of methanol, ethanol, dimethyl sulfoxide, and acetonitrile on in vitro activities of cDNA-expressed human cytochromes P-450. Drug Metab Dispos 27: 246-249.
2. Chen XW, Sneed KB, Pan SY, et al. 2012. Herb-drug interactions and mechanistic and clinical considerations. Curr Drug Metab 13: 640-651.
3. Cuzzolin L, Francini-Pesenti F, Verlato G, Joppi M, Baldelli P, Benoni G. 2010. Use of herbal products among 92 Italian pregnant women: ocus on pregnancy outcome. Pharmacoepidemiol Drug Saf 19: 1151-1158.
4. Dante G, Pedrielli G, Annessi E, Facchinetti F. 2012. Herb remedies during pregnancy: a systematic review of controlled clinical trials. J Matern Fetal Neonatal Med 26: 306-312.
5. Fenner KS, Troutman MD, Kempshall S, et al. 2009. Drug-drug interactions mediated through P-glycoprotein: clinical relevance and in vitro-in vivo correlation using digoxin as a probe drug. Clin Pharmacol Ther 85: 173-181.
6. Food and Drug Administration, U.S. Department of Health and Human Services. 2001. Guidance for industry: bioanalytical method validation. Accessed March 2013 from http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ UCM070107.pdf.
7. Foster BC, Vandenhoek S, Hana J, et al. 2003. In vitro inhibition of human cytochrome P450-mediated metabolism of marker substrates by natural products. Phytomedicine 10: 334-342.
8. Garrard J, Harms S, Eberly LE, Matiak A. 2003. Variations in product choices of frequently purchased herbs: caveat emptor. Arch Intern Med 163: 2290-2295.
9. Glover DD, Amonkar M, Rybeck BF, Tracy TS. 2003. Prescription, over-the-counter, and herbal medicine use in a rural, obstetric population. Am J Obstet Gynecol 188: 1039-1045.
10. Gorski J, Jones D, Haehner-Daniels B, Hamman M, O'Mara Jr. E, Hall S. 1998. The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin. Clin Pharmacol Ther 64: 133-143.
11. Grenier J, Fradette C, Morelli G, Merritt GJ, Vranderick M, Ducharme MP. 2006. Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans. Clin Pharmacol Ther 79: 255-262.
12. Hall HG, Griffiths DL, McKenna LG. 2011. The use of complementary and alternative medicine by pregnant women: a literature review. Midwifery 27: 817-824.
13. Headley J, Northstone K, Simmons H, Golding J. 2004. Medication use during pregnancy: data from the Avon longitudinal study of parents and children. Eur J Clin Pharmacol 60: 355-361.
14. Hellum BH, Hu Z, Nilsen OG. 2007. The induction of CYP1A2, CYP2D6 and CYP3A4 by six trade herbal products in cultured primary human hepatocytes. Basic Clin Pharmacol Toxicol 100: 23-30.
15. Hellum BH, Nilsen OG. 2007. The in vitro inhibitory potential of trade herbal products on human CYP2D6-mediated metabolism and the influence of ethanol. Basic Clin Pharmacol Toxicol 101: 350-358.
16. Hellum BH, Nilsen OG. 2008. In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products. Basic Clin Pharmacol Toxicol 102: 466-475.
17. Hellum BH, Tosse A, Hoybakk K, ThomsenM, Rohloff J, Nilsen OG. 2010. Potent in vitro inhibition of CYP3A4 and P-glycoprotein by Rhodiola rosea. Planta Med 76: 331-338.
18. Ho PC, Saville DJ, Wanwimolruk S. 2001. Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds. J Pharm Pharm Sci 4: 217-227.
19. Ingelman-Sundberg M. 2004. Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future. Trends Pharmacol Sci 25: 193-200.
20. Izzo AA. 2012. Interactions between herbs and conventional drugs: overview of the clinical data. Med Princ Pract 21: 404-428.
21. Kim IS, Kim SY, Yoo HH. 2012. Effects of an aqueous-ethanolic extract of ginger on cytochrome P450 enzyme-mediated drug metabolism. Pharmazie 67: 1007-1009.
22. Kimura Y, Ito H, Hatano T. 2010. Effects of mace and nutmeg on human cytochrome P450 3A4 and 2C9 activity. Biol Pharm Bull 33: 1977-1982.
23. Lilja JJ, Backman JT, Neuvonen PJ. 2007. Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam-probes of CYP2C9, CYP1A2, and CYP3A4. Clin Pharmacol Ther 81: 833-839.
24. Lown K, Bailey D, Fontana R, et al. 1997. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest 99: 2545-2553.
25. Messerer M, Johansson SE, Wolk A. 2001. Use of dietary supplements and natural remedies increased dramatically during the 1990s. J Intern Med 250: 160-166.
26. Ngo N, Yan Z, Graf TN, et al. 2009. Identification of a cranberry juice product that inhibits enteric CYP3A-mediated first-pass metabolism in humans. Drug Metab Dispos 37: 514-522.
27. Nordeng H, Bayne K, Havnen GC, Paulsen BS. 2011. Use of herbal drugs during pregnancy among 600 Norwegian women in relation to concurrent use of conventional drugs and pregnancy outcome. Complement Ther Clin Pract 17: 147-151.
28. Nordeng H, Havnen GC. 2004. Use of herbal drugs in pregnancy: a survey among 400 Norwegian women. Pharmacoepidemiol Drug Saf 13: 371-380.
29. Nordeng H, Ystrom E, Einarson A. 2010. Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol 66: 207-214.
30. Odalovic M, Vezmar Kovacevic S, Nordeng H, Ilic K, Sabo A, Tasic L. 2013. Predictors of the use of medications before and during pregnancy. Int J Clin Pharm [in press]. Doi: 10.1007/ s11096-013-9750-7.
31. Pelkonen O, Turpeinen M, Uusitalo J, Rautio A, Raunio H. 2005. Prediction of drug metabolism and interactions on the basis of in vitro investigations. Basic Clin Pharmacol Toxicol 96: 167-175.
32. Posadzki P, Watson L, Ernst E. 2012. Herb-drug interactions: an overview of systematic reviews. Br J Clin Pharmacol 75: 603-618.
33. Schroder-Aasen T, Molden G, Nilsen OG. 2012. In vitro inhibition of CYP3A4 by the multiherbal commercial product Sambucus force and its main constituents Echinacea purpurea and Sambucus nigra. Phytother Res 26: 1606-1613.
34. Schwertner HA, Rios DC, Pascoe JE. 2006. Variation in concentration and labeling of ginger root dietary supplements. Obstet Gynecol 107: 1337-1343.
35. Scott IM, Leduc RI, Burt AJ, Marles RJ, Arnason JT, Foster BC. 2006. The inhibition of human cytochrome P450 by ethanol extracts of North American botanicals. Pharm Biol 44: 315-327.
36. Sevior DK, Hokkanen J, Tolonen A, et al. 2010. Rapid screening of commercially available herbal products for the inhibition of major human hepatic cytochrome P450 enzymes using the N-in-one cocktail. Xenobiotica 40: 245-254.
37. Sibbritt D, Adams J, Lui CW. 2011. Health service utilisation by pregnant women over a seven-year period. Midwifery 27: 474-476.
38. Singh D, Gupta R, Saraf SA. 2012. Herbs-are they safe enough? an overview. Crit Rev Food Sci Nutr 52: 876-898.
39. Strandell J, Neil A, Carlin G. 2004. An approach to the in vitro evaluation of potential for cytochrome P450 enzyme inhibition from herbals and other natural remedies. Phytomedicine 11: 98-104.
40. Subehan, UT, Iwata H, Kadota S, Tezuka Y. 2006. Mechanismbased inhibition of CYP3A4 and CYP2D6 by Indonesian medicinal plants. J Ethnopharmacol 105: 449-455.
41. Subehan, ZSF, Kadota S, Tezuka Y. 2007. Inhibition on human liver cytochrome P450 3A4 by constituents of fennel (Foeniculum vulgare): identification and characterization of a mechanismbased inactivator. J Agric Food Chem 55: 10162-10167.
42. Thelen K, Dressman JB. 2009. Cytochrome P450-mediated metabolism in the human gut wall. J Pharm Pharmacol 61: 541-558.
43. Tracy TS, Venkataramanan R, Glover DD, Caritis SN. 2005. Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy. Am J Obstet Gynecol 192: 633-639.
44. Usia T, Iwata H, Hiratsuka A,Watabe T, Kadota S, Tezuka Y. 2006. CYP3A4 and CYP2D6 inhibitory activities of Indonesian medicinal plants. Phytomedicine 13: 67-73.
45. Wade C, Chao M, Kronenberg F, Cushman L, Kalmuss D. 2008. Medical pluralism among American women: results of a national survey. J Womens Health (Larchmt) 17: 829-840.
46. Zanger UM, Schwab M. 2013. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther 138: 103-141 Doi: 10.1016/j.pharmthera.2012.12.007.